[f-18]flornaptitril
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2024 (NCT06254469)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Microtubule-associated protein tauBINDING AGENT
MAPT binding agent
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06254469 | Phase 3 | Mar 1, 2024 | CereMark Pharma, LLC |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CereMark Pharma, LLC | For profit | 1 | 1 | 1 | 2024 |
1 organizations
Page 1 / 1